Saturday 17 October 2026 Export VRTX’s income statement to Excel — free account

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $12.0 billion, up 8.90% from fiscal 2024. In the quarter to June 2026, revenue grew 12.5%, EPS grew 7.96% and free cash flow grew 9.25%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years.

499.39 9.36 −1.84%

Follow VRTX

Alert me

Market cap: $129.0B
P/E: 28.8×
Fwd P/E: 25.5×
Dividend yield: —
F-score: 8/9
Altman Z: 12.06
Beneish M: −2.17
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	28.66	26.25	29.31	27.33	+8 more quarters Free account
P/S ratio Full definition →	10.01	9.29	9.66	8.54
P/FCF ratio Full definition →	33.20	30.58	36.30	30.00
P/Operating CF Full definition →	111.98	79.45	232.78	80.64
P/B ratio Full definition →	6.22	5.86	6.21	5.78
Price to Tangible BV Full definition →	6.72	6.35	6.76	6.34
EV/Sales Full definition →	9.42	8.73	9.14	8.04
EV/EBITDA Full definition →	23.72	21.77	25.03	22.47
EV/Operating CF Full definition →	27.62	25.15	30.22	25.34
EV/FCF Full definition →	31.24	28.74	34.36	28.24
Quick Ratio Full definition →	2.54	2.38	2.24	1.84
Current Ratio Full definition →	3.19	3.02	2.90	2.36
Net Debt/EBITDA Full definition →	(6.02)	(6.07)	(5.24)	(5.07)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.49	0.50	0.50	0.50
Operating CF/Net income Full definition →	1.02	1.38	0.42	1.15
Capex/Depreciation Full definition →	(1.99)	(2.39)	(2.68)	(1.89)
Interest Coverage Full definition →	—	—	120.59	359.45
Research and Development Expense of Revenue Full definition →	29.81%	32.19%	30.52%	31.78%
Selling, General and Administrative Expense of Revenue Full definition →	17.46%	16.53%	15.27%	14.47%
Intangible Assets out of Total Assets Full definition →	0.05	0.06	0.06	0.06
Share Based Compensation of Revenue Full definition →	5.11%	5.57%	4.94%	6.34%
Graham Net Nets Full definition →	0.04	0.04	0.04	0.03
Graham Number Full definition →	176.41	170.77	159.40	147.81
Earnings Yield Full definition →	3.49%	3.81%	3.41%	3.66%
Free Cash Flow Yield Full definition →	3.01%	3.27%	2.76%	3.33%
Revenue per Share Full definition →	13.14	11.75	12.48	12.04
Operating CF per Share Full definition →	4.44	5.62	1.95	4.86
Capex per Share Full definition →	(0.44)	(0.52)	(0.58)	(0.40)
Free Cash Flow per Share Full definition →	3.99	5.10	1.36	4.46
Cash per Share Full definition →	30.95	28.52	25.84	24.60
Shareholders Equity per Share Full definition →	79.81	76.20	73.00	67.76
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	79.81	76.20	73.00	67.76
Free Cash Flow Full definition →	1,013.20	1,294.70	348.60	1,139.60
Working Capital Full definition →	8,605.80	7,849.70	7,339.80	6,094.30
Capital Expenditures Full definition →	(112.20)	(133.40)	(149.40)	(101.80)
Net Current Asset Value Full definition →	5,368.30	4,607.80	4,223.80	3,026.10
EV/EBIT Full definition →	24.82	22.78	26.29	23.60
Capex to Sales Full definition →	0.03	0.04	0.05	0.03
Price to Operating Income Full definition →	26.38	24.24	27.78	25.07
Other line items
Average Receivables Full definition →	2,013.90	1,900.60	1,831.10	1,848.50
Average Payables Full definition →	435.90	467.15	437.35	408.05
Average Inventory Full definition →	1,632.20	1,563.20	1,446.10	1,353.30
Average Assets Full definition →	25,730.00	24,682.45	24,088.10	23,551.25
Average Common Equity Full definition →	18,711.65	17,929.10	17,537.70	16,474.85

Show all line items

Columns are period end dates

Stockrow Weekly